BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17309603)

  • 1. p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts.
    Navrátilová J; Horváth V; Kozubík A; Lojek A; Lipsick J; Smarda J
    Differentiation; 2007 Sep; 75(7):592-604. PubMed ID: 17309603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBP sensitizes v-myb-transformed monoblasts to differentiation inducers.
    Smardová J; Nemajerová A; Navrátilová J; Jurdic P; Smarda J
    Differentiation; 2005 Jun; 73(5):222-32. PubMed ID: 16026544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of RARalpha and RXRalpha proteins on growth, viability, and differentiation of v-myb-transformed monoblasts.
    Vodicka P; Sevcíková S; Smardová J; Soucek K; Smarda J
    Blood Cells Mol Dis; 2000 Aug; 26(4):395-406. PubMed ID: 11042040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid.
    Benes P; Macecková V; Zatloukalová J; Kovárová L; Smardová J; Smarda J
    Leuk Res; 2007 Oct; 31(10):1421-31. PubMed ID: 17624428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts.
    Ondrousková E; Povolná K; Vána P; Benes P; Konecná H; Zdráhal Z; Smarda J
    Leuk Res; 2007 Feb; 31(2):221-9. PubMed ID: 16930693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxygenase inhibitors enhance tumor suppressive effects of jun proteins on v-myb-transformed monoblasts BM2.
    Bryja V; Sedlácek J; Zahradnícková E; Sevcíková S; Pacherník J; Soucek K; Hofmanová J; Kozubík A; Smarda J
    Prostaglandins Other Lipid Mediat; 2003 Nov; 72(3-4):131-45. PubMed ID: 14674625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. By-pass of TPA-induced differentiation and cell cycle arrest by the c-Myb DNA-binding domain.
    Engelke U; Smarda J; Lipsick JS
    Oncogene; 1995 Aug; 11(4):735-41. PubMed ID: 7651737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Fos but not v-Fos protein induces programmed cell death of v-myb-transformed monoblasts.
    Zahradnícková E; Soucek K; Sevcíková S; Smardová J; Smarda J
    Cell Mol Life Sci; 2003 Dec; 60(12):2736-48. PubMed ID: 14685696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts.
    Smarda J; Lipsick JS
    Oncogene; 1994 Jan; 9(1):237-45. PubMed ID: 8302585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells.
    Nemajerová A; Smarda J; Jurdic P; Kubala L; Soucek K; Smardová J
    J Hematother Stem Cell Res; 2003 Apr; 12(2):225-35. PubMed ID: 12804181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. v-Myb represses the transcription of Ets-2.
    Wang DM; Sevcikova S; Wen H; Roberts S; Lipsick JS
    Oncogene; 2007 Feb; 26(8):1238-44. PubMed ID: 16909100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts.
    Sevcíková S; Soucek K; Kubala L; Bryja V; Smarda J
    Cell Mol Life Sci; 2002 Oct; 59(10):1690-705. PubMed ID: 12475180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes belonging to the CSF-1 transduction pathway direct p53 tumor suppressor effects to monocytic differentiation in 32D cells.
    Martinelli R; Blandino G; Scardigli R; Crescenzi M; Lombardi D; Sacchi A; Soddu S
    Oncogene; 1997 Jul; 15(5):607-11. PubMed ID: 9247315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effects of colicins E1 and E3 on v-myb-transformed chicken monoblasts.
    Smarda J; Fialová M; Smarda J
    Folia Biol (Praha); 2001; 47(1):11-3. PubMed ID: 11232863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chicken Pdcd4 gene is regulated by v-Myb.
    Schlichter U; Burk O; Worpenberg S; Klempnauer KH
    Oncogene; 2001 Jan; 20(2):231-9. PubMed ID: 11313950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible cross-talk of retinoic acid- and TPA-driven myeloid differentiation pathways.
    Zemanová K; Smarda J
    Folia Biol (Praha); 1998; 44(3):97-105. PubMed ID: 10730850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genes differentially expressed in two types of v-myb-transformed avian myelomonocytic cells.
    Nakano T; Graf T
    Oncogene; 1992 Mar; 7(3):527-34. PubMed ID: 1549365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
    Weber HO; Samuel T; Rauch P; Funk JO
    Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53.
    Sala A; Casella I; Grasso L; Bellon T; Reed JC; Miyashita T; Peschle C
    Cancer Res; 1996 May; 56(9):1991-6. PubMed ID: 8616838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H3 tail positioning and acetylation by the c-Myb but not the v-Myb DNA-binding SANT domain.
    Mo X; Kowenz-Leutz E; Laumonnier Y; Xu H; Leutz A
    Genes Dev; 2005 Oct; 19(20):2447-57. PubMed ID: 16195416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.